Your browser doesn't support javascript.
Allergic respiratory disease care in the COVID-19 era: a EUFOREA statement
Non-conventional in English | WHO COVID | ID: covidwho-276680
ABSTRACT
Spring and Summer 2020 are unique in that the challenges of care for those suffering from pollen allergy coincide with the COVID-19 pandemic. Several considerations are important to allow optimal care of allergic rhinitis (AR) and asthma and hence prevention of coronavirus spread through sneezing, rhinorrhoea and coughing. This compact overview of recommendations by the EUFOREA expert teams on allergic airway diseases and AIT is based on investigation of the current COVID-19 literature in association with the key words above and shared clinical experience of the experts involved. It deals with similarities and differences between AR and coronavirus infection, specific recommendations for allergic disease care in the COVID-19 era, including guidance on allergen specific immunotherapy, AIT.
Search on Google
Collection: Databases of international organizations Database: WHO COVID Type of study: Prognostic study Language: English Document Type: Non-conventional

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: WHO COVID Type of study: Prognostic study Language: English Document Type: Non-conventional